Terms: = Pancreatic cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Prognosis
4 results:
1. PI3K/ c-Myc/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism.
Ni C; Liu W; Zheng K; Guo S; Song B; Jing W; Li G; Li B; Ni C; Shi K; Jin G; Yu G
Int J Biol Sci; 2023; 19(6):1968-1982. PubMed ID: 37063434
[TBL] [Abstract] [Full Text] [Related]
2. Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas.
Imaoka H; Ikeda M; Maehara K; Umemoto K; Ozaka M; Kobayashi S; Terashima T; Inoue H; Sakaguchi C; Tsuji K; Shioji K; Okamura K; Tsujimoto A; Nakamura I; Shirakawa H; Furukawa M; Ueno M; Morizane C; Furuse J
Pancreatology; 2021 Jun; 21(4):738-745. PubMed ID: 33602645
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.
Hong ZF; Zhang WQ; Wang SJ; Li SY; Shang J; Liu F; Shen DY
Biomed Pharmacother; 2020 Mar; 123():109766. PubMed ID: 31846841
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of pancreatic cancer Patients Receiving Neoadjuvant Treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
